Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir in treatment-naïve genotype 1 hepatitis C
NCT00780416Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Nov 2008
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of telaprevir in hepatitis C (HCV), sponsored by Mitsubishi Tanabe Pharma. Started Nov 2008; status: completed.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00780416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00780416.